BlockCon Punta Cana Where Web3 iGaming and Finance Intersect at Global Business Retreat NPR Cuts 28 Journalists in Buyouts and Layoffs Amid Restructuring Arabica Coffee Prices Surge to Record on USColombia Trade Developments Qualcomms Stock Surge Reflects Growing Investor Confidence in AI Device Boom Markets Reprice Fed Rate Path Hot Inflation Data Raises Possibility of Rate Hike Before 2027 Destiny 2 Support Ending Bungies Final Update Signals Shift in LiveService Strategy ASML Q1 2026 Earnings EPS Beats Estimates with 713 Surprise as Stock Holds Steady XFOR Q1 2026 Earnings EPS Beats Estimates Despite Continued PreRevenue Status Stock Declines MIND Technology Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction SRBK Q3 2025 Earnings Positive EPS of 006 Stock Advances 243 Pulmonx Corporation LUNG Q1 2026 Earnings NarrowerThanExpected Loss Keeps Sentiment Positive Interlink Electronics Q3 2025 Earnings Narrowed Loss Beats Expectations Amid Opaque Revenue Picture VOC Energy Trust Holds Steady at 313 Amid Flat Trading Session Lake Superior Acquisition Corp LKSP SPAC Stock Stays Flat Near Trust Value Awaiting Business Combination Beeline Holdings Inc BLNE Declines Sharply Approaches Key Support Level Haemonetics HAE Surges 573 to 6549 Testing Key Resistance Levels Associated BancCorp ASB Faces Headwinds as Shares Dip Nearly 1 Understanding Offer for Sale OFS A Comprehensive Guide for Investors High Templar Tech Limited HTT Q1 2023 Earnings Positive EPS Result Drives Sharp Stock Rally GreenPower Motor GP Tests Key Support After Modest Decline Kaltura Q1 2026 Earnings EPS Surprises to the Upside but Stock Slips Amid Revenue Uncertainty Biogen Q1 2026 Earnings Strong EPS Beat Drives PostMarket Rally Legend Biotech LEGN Q1 2026 Earnings Significant EPS Miss Against Estimates as Stock Rises Mobilicom Limited MOB Q4 2025 Earnings EPS Misses Estimates Sharply as Stock Rises 10 CWK Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Resilience C3ai Q1 2026 Earnings WiderThanExpected Loss Sends Shares Slightly Lower C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution